Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Protalix BioTherapeutics (PLX) over the last 15 years, with Q3 2025 value amounting to $0.03.

  • Protalix BioTherapeutics' EPS (Weighted Average and Diluted) changed 0.0% to $0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.07, marking a year-over-year increase of 15384.62%. This contributed to the annual value of $0.04 for FY2024, which is 5555.56% down from last year.
  • As of Q3 2025, Protalix BioTherapeutics' EPS (Weighted Average and Diluted) stood at $0.03, which was down 0.0% from -$0.05 recorded in Q1 2025.
  • In the past 5 years, Protalix BioTherapeutics' EPS (Weighted Average and Diluted) registered a high of $0.21 during Q2 2023, and its lowest value of -$0.25 during Q2 2021.
  • Over the past 5 years, Protalix BioTherapeutics' median EPS (Weighted Average and Diluted) value was -$0.06 (recorded in 2022), while the average stood at -$0.05.
  • As far as peak fluctuations go, Protalix BioTherapeutics' EPS (Weighted Average and Diluted) tumbled by 56666.67% in 2021, and later skyrocketed by 29090.91% in 2023.
  • Protalix BioTherapeutics' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.14 in 2021, then skyrocketed by 50.0% to -$0.07 in 2022, then changed by 0.0% to -$0.07 in 2023, then soared by 228.57% to $0.09 in 2024, then plummeted by 66.67% to $0.03 in 2025.
  • Its last three reported values are $0.03 in Q3 2025, -$0.05 for Q1 2025, and $0.09 during Q4 2024.